Digital Health Strategy Monitor

August 2026 was a selective but strategically meaningful month for digital health. Funding continued to flow to companies focused on infrastructure, workflow automation and clinical-development enablement rather than broad consumer-health hype. Notable rounds included Faro AI ($37.3M) for agentic AI in clinical development, Metriport ($26M) for healthcare data infrastructure, Hike Medical ($22.5M) for device-based care workflow automation and OmicsBank ($2.25M) for clinical data infrastructure expansion. The clear pattern was that investors kept backing platforms that reduce fragmentation across care delivery, research and data exchange.

M&A remained active as well. Switchboard Health acquired Livara Health and raised more than $5M to move beyond specialty-care navigation into direct musculoskeletal care delivery. The strategic logic was clear: rather than building new clinical capabilities from scratch, digital health companies are increasingly buying care-delivery assets that can be inserted directly into existing payer, provider and employer workflows.

On the regulatory side, Sibel Health received FDA 510(k) clearance for its ANNE One patient-monitoring platform, reinforcing the continued momentum behind provider-grade wearable monitoring. The FDA also kept digital health high on the agenda through updates from its Digital Health Center of Excellence and the ongoing Digital Health Technologies for Drug Development initiative, which signals sustained regulatory interest in software, monitoring and trial-enablement technologies.

In urology, August's most relevant signals came from prostate diagnostics and imaging. Funding activity around prostate imaging and therapy systems, continued visibility for AI tools that detect prostate cancer missed by pathologists, and attention for Clarius Prostate AI all pointed in the same direction: the strongest value creation in urology digital health continues to sit in precision diagnostics, imaging support and AI-enabled clinical decision-making, rather than in broad consumer or telehealth models.

Download the full August 2026 report for the complete deal list, regulatory detail and urology deep-dive.


Here are previous Digital Health Strategy monitors you can read:

Download the full July 2026 report for the complete deal list, regulatory detail and urology deep-dive.

Download the full June 2026 report for the complete deal list, regulatory detail, urology deep-dive and outlook into Q3.

Download the full May report for the complete deal list, regulatory detail, and outlook into June 2026. 

Download the full April report for the complete deal list, regulatory detail, and outlook.